Curio Wealth LLC Invests $112,000 in The Cigna Group (NYSE:CI)

Curio Wealth LLC bought a new position in The Cigna Group (NYSE:CIFree Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 407 shares of the health services provider’s stock, valued at approximately $112,000.

A number of other large investors have also recently made changes to their positions in CI. TCTC Holdings LLC bought a new position in The Cigna Group during the fourth quarter valued at $25,000. Collier Financial bought a new position in The Cigna Group during the fourth quarter valued at $32,000. ORG Wealth Partners LLC bought a new position in The Cigna Group during the fourth quarter valued at $34,000. Prospera Private Wealth LLC bought a new position in The Cigna Group in the 3rd quarter valued at $37,000. Finally, Compagnie Lombard Odier SCmA bought a new position in The Cigna Group in the 4th quarter valued at $37,000. 86.99% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have commented on CI. UBS Group cut their price objective on The Cigna Group from $410.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Truist Financial cut their price objective on The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a research report on Tuesday, February 4th. Royal Bank of Canada set a $355.00 price objective on The Cigna Group in a research note on Friday, January 31st. Oppenheimer lowered their target price on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a report on Friday, January 31st. Finally, Piper Sandler reissued an “overweight” rating and set a $348.00 price target (down previously from $394.00) on shares of The Cigna Group in a research report on Monday, February 3rd. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $372.31.

View Our Latest Stock Report on The Cigna Group

The Cigna Group Price Performance

Shares of CI opened at $313.35 on Monday. The company has a market cap of $85.76 billion, a price-to-earnings ratio of 25.60, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The company has a 50 day moving average of $296.79 and a two-hundred day moving average of $316.23.

The Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the company earned $6.79 earnings per share. As a group, analysts predict that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a $1.51 dividend. The ex-dividend date is Wednesday, March 5th. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 dividend on an annualized basis and a yield of 1.93%. The Cigna Group’s dividend payout ratio (DPR) is 49.35%.

Insider Buying and Selling

In related news, insider Noelle K. Eder sold 9,944 shares of The Cigna Group stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the completion of the sale, the insider now owns 13,406 shares of the company’s stock, valued at $4,289,920. The trade was a 42.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Nicole S. Jones sold 4,904 shares of The Cigna Group stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the sale, the insider now directly owns 29,421 shares of the company’s stock, valued at $9,065,198.52. This trade represents a 14.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 41,375 shares of company stock worth $12,866,600 in the last three months. Corporate insiders own 0.60% of the company’s stock.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Recommended Stories

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.